Comparison of a Novel Transperineal Targeted Fusion Biopsy System to Conventional Transrectal Targeted Fusion Biopsy

Recruiting

Comparison of a Novel Transperineal Targeted Fusion Biopsy System to Conventional Transrectal Targeted Fusion Biopsy

Sponsor:

Dr. Nicola Schieda

Code:

NCT03936127

Conditions

Prostate Cancer

Eligibility Criteria

Sex: Male

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Ultrasound (US) Targeted Fusion Biopsy

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-07-12. This information was provided to ClinicalTrials.gov by Dr. Nicola Schieda on 2022-10-25.